|
VDR expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.12340050992555E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80670000071714E-08 |
| Normal-vs-Stage2 |
1.274330E-02 |
| Normal-vs-Stage3 |
4.43300000041447E-07 |
| Normal-vs-Stage4 |
3.68019999996694E-06 |
| Stage1-vs-Stage2 |
4.352000E-01 |
| Stage1-vs-Stage3 |
2.887600E-01 |
| Stage1-vs-Stage4 |
1.151440E-01 |
| Stage2-vs-Stage3 |
1.970350E-01 |
| Stage2-vs-Stage4 |
1.005190E-01 |
| Stage3-vs-Stage4 |
6.066200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.94609949955816E-10 |
| Normal-vs-AfricanAmerican |
1.997100E-03 |
| Normal-vs-Asian |
4.31570000000159E-05 |
| Caucasian-vs-AfricanAmerican |
9.700800E-01 |
| Caucasian-vs-Asian |
4.903400E-01 |
| AfricanAmerican-vs-Asian |
6.715600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03189999999909E-05 |
| Normal-vs-Female |
1.62780011692121E-10 |
| Male-vs-Female |
8.478500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.98900000025759E-07 |
| Normal-vs-Age(41-60Yrs) |
5.78340000334521E-08 |
| Normal-vs-Age(61-80Yrs) |
5.71959999999816E-05 |
| Normal-vs-Age(81-100Yrs) |
3.370000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.824600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.795000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.166200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.482200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.312800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.729800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.759850E-01 |
| Classical-VS-Follicular |
2.27069999999552E-05 |
| Classical-VS-Other |
7.991600E-02 |
| Classical-VS-Normal |
7.51554374289753E-12 |
| Tall-VS-Follicular |
8.44440000000724E-05 |
| Tall-VS-Other |
1.006260E-02 |
| Tall-VS-Normal |
7.95639999995323E-07 |
| Follicular-VS-Other |
5.492000E-01 |
| Follicular-VS-Normal |
4.539700E-02 |
| Other-VS-Normal |
8.113400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83289999999836E-06 |
| Normal-vs-N1 |
8.39870000000076E-05 |
| N0-vs-N1 |
2.410200E-01 |
|
|
